|
|
Other links at Articles > Diabetes and Endocrinology |
| 2. |
Metabolic Syndrome Complicates Hypertension Management
|
|
|
The presence of metabolic syndrome negatively affects cardiovascular risk profile and response to treatment in hypertensive postmenopausal women, Italian researchers report in the November issue of Hypertension. Reuters Health Information
|
| 3. |
Covidien Recalls Syringes Posing Risk to Diabetics
|
|
|
U.S. health officials warned doctors and patients on Wednesday that Covidien Ltd was recalling nearly half a million single-use syringes that could pose a serious risk to diabetics. Reuters Health Information
|
| 4. |
Why and When to Implement Incretin Therapy
|
|
|
Two agents are currently available in the United States that act upon the incretin hormone system -- exenatide (Byetta), a twice-daily glucagon-like peptide-1 (GLP-1) receptor agonist, and sitagliptin (Januvia), a dipeptidyl peptidase-4 (DPP-4) inhibitor.
|
|
|
